Maggie Kelly

Vice President

Derrick Mayes

Managing Partner

Ryan Michaels

Junior Analyst

Ross O'Brien

Founder and CEO

Robert Toth Jr.

Scientific Operating Partner

4 past transactions

Nalu Bio

Series A in 2023
Nalu Bio is a biotech company focused on creating cannabinoids through innovative chemical processes rather than traditional plant extraction. This novel approach allows Nalu Bio to produce pure and safe ingredients that are environmentally sustainable, utilizing significantly less land, water, and energy compared to conventional methods. The company's proprietary chemistry platform ensures consistency and quality by generating identical batches of cannabinoids, free from contaminants such as pesticides and THC. Targeting both consumer and pharmaceutical markets, Nalu Bio aims to disrupt the cannabinoid industry by providing a reliable source of high-quality ingredients that meet the growing demand for safe and effective products.

FloraWorks

Series A in 2022
FloraWorks is a manufacturer and supplier of hemp-derived cannabinoids, focusing on the discovery of rare and novel compounds for commercial and therapeutic applications. The company collaborates with specialized biotech enterprises to develop scalable manufacturing processes for cannabinoids that show significant therapeutic potential. FloraWorks conducts the necessary toxicology and efficacy research to ensure these products are viable for market introduction. Their work aims to address a range of health conditions, including sleep disorders and Alzheimer's disease, thereby contributing to advancements in both consumer and healthcare sectors.

Nalu Bio

Seed Round in 2021
Nalu Bio is a biotech company focused on creating cannabinoids through innovative chemical processes rather than traditional plant extraction. This novel approach allows Nalu Bio to produce pure and safe ingredients that are environmentally sustainable, utilizing significantly less land, water, and energy compared to conventional methods. The company's proprietary chemistry platform ensures consistency and quality by generating identical batches of cannabinoids, free from contaminants such as pesticides and THC. Targeting both consumer and pharmaceutical markets, Nalu Bio aims to disrupt the cannabinoid industry by providing a reliable source of high-quality ingredients that meet the growing demand for safe and effective products.

LeafWorks

Series A in 2020
LeafWorks Inc. is a company that specializes in genetic testing services aimed at natural product businesses, particularly within the cannabis and hemp sectors. Founded in 2016 and based in Sebastopol, California, LeafWorks provides a range of services that include botanical identification, cannabis and hemp DNA sex tests, pathogen identification, feminized seed certification, cultivar registration, and genetic consulting. By offering these services, LeafWorks helps clients accurately identify raw materials, protect their genetic intellectual property, and enhance crop efficiency. The company's focus is on ensuring accurate labeling and preventing fraud in the marketplace, thereby supporting the growth and integrity of the cannabis and herbal industries.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.